Key result
Leaflet modification proves feasible across calcific aortic valves but efficacy varies by specific valve features.
Why the study?
Is leaflet modification (BASILICA or intraleaflet deployment) feasible and effective in calcific native and bioprosthetic surgical aortic valves?
Is leaflet modification (BASILICA or intraleaflet deployment) feasible and effective in calcific native and bioprosthetic surgical aortic valves?
Benchtop assessment demonstrates that leaflet modification techniques like BASILICA are feasible across a spectrum of calcific disease in native and bioprosthetic aortic valves.
Bench findings on splay variation warrant clinical caution; leaves open optimal SAV selection for leaflet modification in vivo.
BACKGROUND: Leaflet modification (LM) techniques, including electrosurgical and mechanical BASILICA (bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction) and intraleaflet deployment, are important in the lifetime management of aortic valve disease. However, benchtop assessment is limited. OBJECTIVES: The aim of this study was to provide a benchtop assessment of LM in native valves and bioprosthetic surgical aortic valves (SAVs). METHODS: Features of calcific native aortic valves (n = 100) and naive SAVs (7 types) were assessed. Calcific native cusps (n = 13) and SAV leaflets (n = 14) stratified by calcific load were modified by electrosurgical or mechanical BASILICA or intraleaflet deployment with assessment of splay, laceration patterns, and embolic debris. The impact of leaflet length and valve-in-valve implantation on splay area was analyzed. RESULTS: = 0.84) and generally increased with simulated valve expansion, but this varied by SAV type. CONCLUSIONS: Features of native aortic valves and SAVs impact the efficacy of LM. LM is feasible across a spectrum of calcific disease. Further study is required.
No takes yet. Share an insight, caveat, or question.
Loretz et al. (2026) studied this question. Leaflet modification is feasible across a spectrum of calcific disease in native and surgical bioprosthetic aortic valves, although its efficacy is impacted by specific valve features.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: